BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37100501)

  • 21. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of MRI-based radiomic features for predicting lymph node metastasis in patients with cervical cancer.
    Li L; Zhang J; Zhe X; Tang M; Zhang X; Lei X; Zhang L
    Eur J Radiol; 2022 Jun; 151():110243. PubMed ID: 35366583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
    Falcetta FS; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT; Rosa DD
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD005342. PubMed ID: 27873308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MRI radiomics in overall survival prediction of local advanced cervical cancer patients tread by adjuvant chemotherapy following concurrent chemoradiotherapy or concurrent chemoradiotherapy alone.
    Wei G; Jiang P; Tang Z; Qu A; Deng X; Guo F; Sun H; Zhang Y; Gu L; Zhang S; Mu W; Wang J; Tian J
    Magn Reson Imaging; 2022 Sep; 91():81-90. PubMed ID: 35636572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis.
    Medina-Lara A; Grigore B; Lewis R; Peters J; Price S; Landa P; Robinson S; Neal R; Hamilton W; Spencer AE
    Health Technol Assess; 2020 Nov; 24(66):1-332. PubMed ID: 33252328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomograms Combining Clinical and Imaging Parameters to Predict Recurrence and Disease-free Survival After Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.
    Zhang Y; Liu L; Zhang K; Su R; Jia H; Qian L; Dong J
    Acad Radiol; 2023 Mar; 30(3):499-508. PubMed ID: 36050264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
    Choi CH; Chung JY; Kang JH; Paik ES; Lee YY; Park W; Byeon SJ; Chung EJ; Kim BG; Hewitt SM; Bae DS
    Gynecol Oncol; 2020 May; 157(2):437-443. PubMed ID: 32107047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial intelligence with magnetic resonance imaging for prediction of pathological complete response to neoadjuvant chemoradiotherapy in rectal cancer: A systematic review and meta-analysis.
    Jia LL; Zheng QY; Tian JH; He DL; Zhao JX; Zhao LP; Huang G
    Front Oncol; 2022; 12():1026216. PubMed ID: 36313696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis.
    Arbyn M; Redman CWE; Verdoodt F; Kyrgiou M; Tzafetas M; Ghaem-Maghami S; Petry KU; Leeson S; Bergeron C; Nieminen P; Gondry J; Reich O; Moss EL
    Lancet Oncol; 2017 Dec; 18(12):1665-1679. PubMed ID: 29126708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant platinum-based chemotherapy for early stage cervical cancer.
    Rosa DD; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT
    Cochrane Database Syst Rev; 2012 Jun; 6(6):CD005342. PubMed ID: 22696349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The risk prediction models for occurrence of cervical cancer: a systematic review].
    He BJ; Chen WY; Liu LL; Zhu HY; Cheng HZ; Zhang YX; Wang SF; Zhan SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1855-1862. PubMed ID: 34814624
    [No Abstract]   [Full Text] [Related]  

  • 37. A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Lee YJ; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Gynecol Oncol; 2017 Mar; 144(3):536-540. PubMed ID: 28108027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
    Park SH; Hahm MH; Bae BK; Chong GO; Jeong SY; Na S; Jeong S; Kim JC
    Radiat Oncol; 2020 Apr; 15(1):86. PubMed ID: 32312283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Performance of Artificial Intelligence-Based Models for the Detection of Early Esophageal Cancers in Barret's Esophagus: A Meta-Analysis of Patient-Based Studies.
    Bhatti KM; Khanzada ZS; Kuzman M; Ali SM; Iftikhar SY; Small P
    Cureus; 2021 Jun; 13(6):e15447. PubMed ID: 34258114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.